SCN5A p.Phe2003Val
c.6007T>G · rs41311117 · VCV68022
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0674 | likely benign |
|---|---|---|
| REVEL | 0.566 | indeterminate |
| SaProt | LLR -5.21 | tolerated |
| ⇒ AlphaMissense and SaProt both call this tolerated; REVEL is indeterminate. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 1.4 | GERP 0.53, phastCons 0.99 |
| Regional constraint | o/e 0.98 | unconstrained · MANE · 348 bp · p 0.81 · regional, not allelic |
| Overall | ||
| CADD | 7.036 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
⚠ Isoform check: AlphaMissense numbered on a different transcript (AM F2004V vs ClinVar F2003V) — verify the residue.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 0.118% | 848 |
| Remaining individualsnot grpmax-eligible | 0.00678% | 14,747 |
| European (non-Finnish)grpmax | 0.000703% | 142,180 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- SCN5A
- Protein
- p.Phe2003Val
- Coding
- c.6007T>G
- MANE Select
- NM_000335
- dbSNP
- rs41311117
- Type
- single nucleotide variant
- Location
- chr3:38550362 (GRCh38)
- Gene constraint
- LOEUF 0.372 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 68.02 · 16 PDB
- Residue 2004 UniProt numbering
- a UniProt-annotated variant site (in lqt3 and brgda1; also found in patients with atrial fibrillation; results in channels with decreased peak and persistent current amplitudes; increased closed-state and slow inactivation; decelerated recovery from inactivation); a UniProt-annotated variant site (in brgda1 and lqt3); the 'disordered' region
Disease context
cardiac rhythm disease — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: progressive familial heart block, type 1ABrugada syndrome 1dilated cardiomyopathy 1Eventricular fibrillation, paroxysmal familial, type 1long QT syndrome 3familial long QT syndromesick sinus syndrome 1
Similar variants
- SCN5A p.Phe2003Ile Uncertain significance ★★ ⚠ same residue
- SCN5A p.Phe2003= Likely benign ★★ same residue
- SCN5A p.Phe2003Leu Conflicting classifications of pathogenicity ★ ⚠ same residue
- SCN5A p.Phe2003Ser Conflicting classifications of pathogenicity ★ ⚠ same residue
- SCN5A p.Phe2003Cys Uncertain significance ★ ⚠ same residue
- SCN5A c.1140+1G>A Pathogenic/Likely pathogenic ★★ same condition
- SCN5A c.1338+2T>A Pathogenic/Likely pathogenic ★★ same condition
- SCN5A c.2263-2A>G Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/scn5a-p-phe2003val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown